Mereo Biopharma Group PLC
NASDAQ:MREO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
UK |
|
T
|
Trisula Textile Industries Tbk PT
IDX:BELL
|
ID |
|
B
|
Biolog Device Co Ltd
KOSDAQ:208710
|
KR |
|
Y
|
Youngpoong Corp
KRX:000670
|
KR |
|
G
|
GG Dandekar Machine Works Ltd
BSE:505250
|
IN |
|
Henan Yuguang Gold & Lead Co Ltd
SSE:600531
|
CN |
|
S
|
Slang Worldwide Inc
CNSX:SLNG
|
CA |
|
Haitian International Holdings Ltd
HKEX:1882
|
CN |
|
Michael Hill International Ltd
ASX:MHJ
|
AU |
|
Ubiquitous AI Corp
TSE:3858
|
JP |
|
Brii Biosciences Ltd
HKEX:2137
|
CN |
|
Heron Resources Ltd
ASX:HRR
|
AU |
|
Waratah Minerals Ltd
ASX:WTM
|
AU |
|
E
|
ETS Holdings Co Ltd
TSE:1789
|
JP |
|
Otter Tail Corp
NASDAQ:OTTR
|
US |
|
SPC Nickel Corp
XTSX:SPC
|
CA |
|
O
|
Obara Group Inc
TSE:6877
|
JP |
Wall Street
Price Targets
MREO Price Targets Summary
Mereo Biopharma Group PLC
According to Wall Street analysts, the average 1-year price target for
MREO
is 1.785 USD
with a low forecast of 0.505 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MREO's stock price target?
Price Target
1.785
USD
According to Wall Street analysts, the average 1-year price target for
MREO
is 1.785 USD
with a low forecast of 0.505 USD and a high forecast of 3.15 USD.
What is Mereo Biopharma Group PLC's Revenue forecast?
Projected CAGR
334%
The
compound annual growth rate
of Mereo Biopharma Group PLC's revenue for the next 3 years is
334%.
